Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $13.0550 (1.6%) ($13.0550 - $13.0550) on Thu. Dec. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.4% (three month average) | RSI | 76 | Latest Price | $13.0550(1.6%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 0.9% a day on average for past five trading days. | Weekly Trend | FOLD advances 7.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) XBI(97%) IBB(83%) IPO(82%) XAR(81%) XLK(78%) | Factors Impacting FOLD price | FOLD will decline at least -1.7% in a week (0% probabilities). URA(-20%) VIXM(-19%) TBT(-6%) EDOC(-6%) BNDX(1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.7% (StdDev 3.4%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $12.89(1.28%) | 10 Day Moving Average | $12.41(5.2%) | 20 Day Moving Average | $11.71(11.49%) | To recent high | -0.9% | To recent low | 31% | Market Cap | $3.371b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |